An update on drug-drug interactions between antiretroviral therapies and drugs of abuse in HIV systems

Expert Opin Drug Metab Toxicol. 2020 Nov;16(11):1005-1018. doi: 10.1080/17425255.2020.1814737. Epub 2020 Aug 31.

Abstract

Introduction: While considerable progress has been made in the fight against HIV/AIDS, to date there has not been a cure, and millions of people around the world are currently living with HIV/AIDS. People living with HIV/AIDS have substance abuse disorders at higher rates than non-infected individuals, which puts them at an increased risk of drug-drug interactions.

Areas covered: Potential drug-drug interactions are reviewed for a variety of potential drugs of abuse, both licit and illicit. These drugs include alcohol, cigarettes or other nicotine delivery systems, methamphetamine, cocaine, opioids, and marijuana. Potential interactions include decreased adherence, modulation of drug transporters, or modulation of metabolic enzymes. We also review the relative incidence of the use of these drugs of abuse in People living with HIV/AIDS.

Expert opinion: Despite considerable improvements in outcomes, disparities in outcomes between PLWHA who use drugs of abuse, vs those who do not still exist. It is of critical necessity to improve outcomes in these patients and to work with them to stop abusing drugs of abuse.

Keywords: Antiretrovirals; HIV-1; drug transporters; drugs of abuse; metabolic enzymes.

Publication types

  • Review

MeSH terms

  • Animals
  • Anti-HIV Agents / administration & dosage
  • Anti-HIV Agents / adverse effects*
  • Drug Interactions
  • HIV Infections / drug therapy*
  • Humans
  • Illicit Drugs / adverse effects
  • Medication Adherence
  • Substance-Related Disorders / complications*
  • Substance-Related Disorders / epidemiology

Substances

  • Anti-HIV Agents
  • Illicit Drugs